-
ASCO Abstract Hints At Loxo Oncology (LOXO) FDA Approval - Citi
-
Loxo Oncology (LOXO) PT Raised to $178 at Citi
-
Loxo Oncology (LOXO) PT Raised to $151 at Citi
-
Loxo Oncology (LOXO) PT Lowered to $108 at Citi on Bayer Collaboration for Laro & LOXO-195; 'Deal Not Exactly What We Expected, But Still Very Good'
-
Loxo Oncology to Present at Upcoming Investor Conferences
-
Loxo Oncology Announces the Closing of its Follow-On Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Loxo Oncology (LOXO) Prices 3.15M Share Follow-On Offering at $72/Sh
-
Loxo Oncology Prices Follow-On Offering of Common Stock
-
Loxo Oncology (LOXO) Announces Common Offering
-
Loxo Oncology Announces Proposed Public Offering of Common Stock
-
Citi Reinstates Loxo Oncology (LOXO) at Buy, "Stunning ASCO Data Surpass Our High Expectations
-
Citi Downgrades Loxo Oncology (LOXO) to Neutral
-
Loxo Oncology Announces the Closing of its Follow-On Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Loxo Oncology (LOXO) Prices 3.87M Share Offering at $31
-
Loxo Oncology Prices Follow-On Offering of Common Stock
-
Loxo Oncology (LOXO) to Offers Shares of Common Stock
-
Loxo Oncology Announces Proposed Public Offering of Common Stock
-
Loxo Oncology to Present at Upcoming Investor Conferences
-
Loxo Oncology Announces the Closing of its Follow-On Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Loxo Oncology (LOXO) Prices 1.68M Common Stock Offering at $21.50/Share
-
Loxo Oncology Prices Follow-On Offering of Common Stock
-
Loxo Oncology (LOXO) Plans Common Stock Offering
-
Loxo Oncology Announces Proposed Public Offering of Common Stock
-
Citi Starts Loxo Oncology (LOXO) at Buy
-
Loxo Oncology Announces the Closing of Its Follow-On Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Loxo Oncology (LOXO) Prices 2.5M Common Follow-on at $26.50/Share
-
Loxo Oncology Prices Follow-On Offering of Common Stock
-
Loxo Oncology (LOXO) Commences 2M Share Common Stock Offering
-
Loxo Oncology Announces Proposed Public Offering of Common Stock

